What is AptarGroup's pharma — adjusted EBITDA?

AptarGroup (ATR) reported pharma — adjusted EBITDA of $146.22M in Q1 2026.

How has AptarGroup's pharma — adjusted EBITDA changed year-over-year?

AptarGroup's pharma — adjusted EBITDA increased by 2.6% year-over-year, from $142.45M to $146.22M.

What does pharma — adjusted EBITDA mean?

A normalized measure of the segment's operational cash profitability.

How do you interpret pharma — adjusted EBITDA?

Higher EBITDA indicates stronger operational performance and cash-generating capability.

How does pharma — adjusted EBITDA compare across companies?

Widely used across all industries to compare operational profitability regardless of capital structure.

AptarGroup ATR Pharma — Adjusted EBITDA

Similar metrics at other companies

ESIPerformance Materials — Adjusted EBITDA

$56.08M+14.3%

IFFPharma Solutions — Adjusted Operating EBITDA

$22M-62.1%

LYBAPS — EBITDA

$58M+26.1%

IROperating Segments — Adjusted EBITDA

$150.7M+50.2%

EHCOperating Segments — Adjusted EBITDA

$257.3M+12.2%

HOperating Segments — Adjusted EBITDA

$228M-5.4%

Other financials

Income statement

See full

Revenue$982.9M+10.8%

Gross profit$351.9M+4.6%

Operating income$107.5M-5.2%

Net income$72.7M-7.8%

EPS (diluted)$1.12-4.3%

Balance sheet

See full

Cash & equivalents$225.0M+78.8%

Total debt$1.4B+32.7%

Total equity$2.6B+3.6%

Total assets$5.1B+12.6%

Cash flow

See full

Operating cash flow$118.7M+43.5%

CapEx$65.4M+15.0%

Free cash flow$53.3M+106%

Valuation

See full

Market cap$7.68B-17.9%

Enterprise value$8.89B-13.9%

P/E19.9×-5.4×

P/S2×-0.6×

Profitability

See full

Gross margin36.7%-1.6pp

Operating margin12.8%-1.2pp

Net margin10%-0.4pp

FCF margin8.4%-2.1pp

Returns & leverage

See full

Return on equity15%-0.2pp

Debt / equity0.5×+0.1×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept atr:AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's pharma — adjusted ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AptarGroup's pharma — adjusted EBITDA?: AptarGroup (ATR) reported pharma — adjusted EBITDA of $146.22M in Q1 2026.
How has AptarGroup's pharma — adjusted EBITDA changed year-over-year?: AptarGroup's pharma — adjusted EBITDA increased by 2.6% year-over-year, from $142.45M to $146.22M.
What does pharma — adjusted EBITDA mean?: A normalized measure of the segment's operational cash profitability.
How do you interpret pharma — adjusted EBITDA?: Higher EBITDA indicates stronger operational performance and cash-generating capability.
How does pharma — adjusted EBITDA compare across companies?: Widely used across all industries to compare operational profitability regardless of capital structure.